[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 编委信息

翟创彦

职称:副研究员

单位:南方医科大学

社会任职:广东省药学会第一、二届核药学专业委员会常务委员,广东核学会第一、二届核药学专委会委员,广州欧美同学会第一次代表大会会员代表,广州欧美同学会•广州留学人员联谊会白云分会第一、二届理事会理事

个人简介

翟创彦,博士,副研究员。中国认证毒理学家。奥地利因斯布鲁克医科大学医学专业博士、博士后,公安部物证鉴定中心访问学者。主持国家自然科学基金2项,参与了一系列全国重大疑难案件的鉴定工作和国家领导人、国家重大活动的食品安保工作。主要从事污水流行病学和医学影像学研究工作。

教育经历

  • 2025.03 - 2025.04:2025 年广州市党外处级干部进修班
  • 2019.11 - 2021.10: SMU-FAIMER 美中高等医学教育高级研修班医学教育
  • 2012.11 - 2015.12: Medical University Innsbruck 博士研究生:医学
  • 2006.09 - 2009.07: 中国原子能科学研究院硕士研究生:分析化学
  • 2002.09 - 2006.06: 河北大学本科:材料化学

学术贡献

  • 1、[1] Zhang D#, Li G#, Jiang B, Li Y, Zhao X, Zhang Z, Chen N, Zhang X, Wang M*, Zhang G*, and Zhai C*. Synergistic Methylene Blue Driven FAPI Uptake Mechanism Advancing the Detection of Myocardial Fibrosis in Hypertensive Heart Disease. Molecular Pharmaceutics, 2025, 22(10): 6193–6202 https://doi.org/10.1021/acs.molpharmaceut.5c00913
  • 2、[2] Zhai C and Bobba KN. Editorial: Recent advances in radiotheranostics. Frontiers in Nuclear Medicine,2024, 4:1520778 https://doi.org/10.3389/fnume.2024.1520778
  • 3、[3] Zhai C. Visual analysis of postmortem interval estimation trends and collaborative networks: a 15-year study (2006 – 2020). Forensic Science, Medicine and Pathology, 2025, 21: 599-609 https://doi.org/10.1007/s12024-024-00908-2
  • 4、[4] Zhang D#, Shi Y#, Kong J, Chen N, Li G, Wang M, Zhang G*, Zhai C*. Early diagnosis and staging of paraquat-induced pulmonary fibrosis using [18F]F-FAPI-42 PET/CT imaging. EJNMMI Research 2024, 14, 57 https://doi.org/10.1186/s13550-024-01118-1
  • 5、[5] Zhao X, Zhang G, Chen J, Li Z, Shi Y, Li G, Zhai C*, Nie L*. A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging. European Journal of Nuclear Medicine and Molecular Imaging 2024, 51(6): 1593–1604 https://doi.org/10.1007/s00259-024-06691-0 (ESI 高被引论文和热点论文)
  • 6、[6] Zhai C, He S, Ye Y, Rangger C, Kaeopookum P, Summer D, Haas H, Kremser L, Lindner H, Foster J, Sosabowski J, Decristoforo C*. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89. Biomolecules 2019;9, 91 https://doi.org/10.3390/biom9030091
  • 7、[7] Zhai C, Franssen G M, Petrik M, Laverman P, Summer D, Rangger C, Haubner R, Haas H, Decristoforo C*. Comparison of 68Ga-labeled Fusarinine C-based multivalent RGD conjugates and [68Ga]NODAGA-RGD-in vivo imaging studies in human xenograft tumors. Molecular imaging and biology, 2016, 18(5): 758-767 https://doi.org/10.1007/s11307-016-0931-3
  • 8、[8] Zhai C, Summer D, Rangger C, Franssen G M, Laverman P, Haas H, Petrik M, Haubner R, Decristoforo C*. Novel bifunctional cyclic chelator for 89Zr labeling-radiolabeling and targeting properties of RGD conjugates. Molecular pharmaceutics, 2015, 12(6): 2142-2150 https://doi.org/10.1021/acs.molpharmaceut.5b00128
  • 9、[9] Zhai C, Summer D, Rangger C, Haas H, Haubner R, Decristoforo C*. Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68. Journal of labelled compounds & radiopharmaceuticals, 2015, 58(5): 209-214 https://doi.org/10.1002/jlcr.3286

工作经历

  • 2025.05 - 至今: 南方医科大学第三附属医院科技管理特派员
  • 2016.10 - 至今: 南方医科大学讲师,副研究员
  • 2024.01 – 2025.01:Emory University 访问学者(访问教授)
  • 2018.09 – 2019.08:公安部物证鉴定中心访问学者
  • 2016.01 - 2016.07: Medical University Innsbruck 博士后
  • 2010.07 - 2016.02: 广东省人民医院化学师
  • 2009.08 - 2010.06: 中国原子能科学研究院助理工程师